首页 | 本学科首页   官方微博 | 高级检索  
检索        


Hepatitis B virus (HBV) reverse seroconversion (RS) can be prevented even in non‐responders to hepatitis B vaccine after allogeneic stem cell transplantation: long‐term analysis of intervention in RS with vaccine for patients with previous HBV infection
Authors:M Takahata  S Hashino  M Onozawa  A Shigematsu  J Sugita  K Fujimoto  T Endo  T Kondo  J Tanaka  M Imamura  T Teshima
Institution:1. Department of Hematology, Hokkaido University Hospital, , Sapporo, Japan;2. Health Care Center, Hokkaido University, , Sapporo, Japan;3. Department of Hematology, Tokyo Women's Medical University Hospital, , Tokyo, Japan;4. Department of Hematology, Sapporo Hokuyu Hospital, , Sapporo, Japan
Abstract:
Keywords:HBV  vaccine  reverse seroconversion  stem cell transplantation
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号